| Literature DB >> 35894372 |
Carolina Vicaria Rodrigues D'Aurea1, Cristina Frange2, Dalva Poyares2, Altay Alves Lino de Souza2, Mario Lenza1.
Abstract
OBJECTIVE: To systematically review the effects (benefits and harms) of different types of physical exercise on insomnia outcomes in adult populations with no mood disorders. Objective and subjective sleep outcomes and related mismatches were analyzed.Entities:
Mesh:
Year: 2022 PMID: 35894372 PMCID: PMC9299578 DOI: 10.31744/einstein_journal/2022AO8058
Source DB: PubMed Journal: Einstein (Sao Paulo) ISSN: 1679-4508
Figure 1Flow chart (PRISMA) depicting results of the systematic literature search following application of inclusion and exclusion criteria
Summary of articles included in the review and the meta-analysis
| Studies | n | Mean age (±SD) or range | Insomnia classification | Intervention(s) and controls/duration | Outcomes |
|---|---|---|---|---|---|
| Passos et al. (15) Brazil | 48 | Inactive adults Both sexes 44.4 (±8.0) | Clinical diagnosis of insomnia (DSM-IV + ICSD-2) | 4 groups: G1 = moderate-intensity aerobic exercise (50 minutes, 1 session/week) G2 = high-intensity aerobic exercise (50 minutes, 1 session/week) G3 = moderate-intensity resistance exercise (50 minutes, 1 session/week) Ctrl = no treatment | PSG: TST, SE, SOL, WASO Sleep diary: TST, SE, SOL, WASO |
| Reid et al. (36) United States of America | 17 | Sedentary adults Both sexes 61.6 (± 4.3) | Clinical diagnosis of insomnia (ACT + 7 day sleep diary) | 2 groups: G1 = moderate aerobic physical activity+ sleep hygiene (increasing from 10 to 40 minutes each week, 4 sessions/week) Ctrl = sleep hygiene 4 months | PSQI Epworth Sleepiness Scale SF-36 |
| Afonso et al. (33) Brazil | 44 | Postmenopausal women 50-65 | Clinical diagnosis of insomnia | 3 groups: G1 = yoga (1 hour, 2 sessions/week) G2 = passive stretching (1 hour, 1 session/week) Ctrl = no treatment 4 months | PSG: TST, SE, SOL, WASO ISI MENQOL |
| Irwin et al. (37) United States of America | 123 | Older adults Both sexes 55-85 | Clinical diagnosis of insomnia (DSM-IV + ICSD-2) | 3 groups: G1 = CBT (2 hours, 2 sessions/week) G2 =Tai Chi (2 hours, 2 sessions/week) Ctrl = sleep seminar education + sleep hygiene (2 hours, 2 sessions/week) 4 months | PSG: TST, SE, SOL, WASO Sleep diary: TST, SE, SOL, WASO PSQI Epworth Sleepiness Scale AIS |
| Hartescu et al. (35) United Kingdom | 41 | Inactive adults Both sexes 59.80 (±9.5) | Clinical diagnosis of insomnia (Research Diagnostic Criteria) | 2 groups: G1 = moderate to vigorous physical activity (≥150 minutes, 1 session/week) Ctrl = no treatment 6 months | Epworth Sleepiness Scale ISI EQ5D-5L |
| D’Aurea et al. (34) Brazil | 28 | Inactive adults Both sexes 30-55 | Clinical diagnosis of insomnia | 3 groups: G1 = resistance exercise (1 hour, 3 sessions/week) G2 = low-intensity stretching (1 hour, 3 sessions/week) Ctrl = no treatment 4 months | PSG: TST, SE, SOL, WASO ACT: TST, SE, SOL, WASO PSQI ISI SF-36 |
SD: standard deviation; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders; ICSD-2: International Classification of Sleep Disorders; G: group; Ctrl: Control Group; PSG: polysomnography; TST: total sleep time; SE: sleep efficiency; SOL: sleep onset latency; WASO: wake after sleep onset; ACT: actigraphy; PSQI: Pittsburgh Sleep Quality Index; SF-36: Short Form Health Survey 36; ISI: Insomnia Severity Index; MENQOL: Menopause-specific Quality of Life Questionnaire; CBT: cognitive behavioral therapy; AIS: Athens Insomnia Scale; EQ5D-5L:EUROQOL5D5L.
Figure 2Classification of risk of bias expressed as percentages across selected studies
Summary of findings for the main comparison
| Effects of physical exercise in insomnia and control patients | |||||
|---|---|---|---|---|---|
| Patient or population: adults with insomnia Intervention: physical exercise Comparison: Control Group (no activity) | |||||
| Outcomes | Illustrative comparative risks* (95%CI) | Number of participants (studies) | Quality of evidence (GRADE) | Comments | |
| Assumed risk | Corresponding risk | ||||
| Control Group | Physical Exercise | ||||
| PSG - TST; PSG is the gold standard for analysis of physiological variables affecting sleep. Follow-up: 4 months | Mean TST in Control Groups was 341.3 minutes | SMD 0.09 lower (0.45 lower to 0.28 higher) | 121 participants (3 studies) | ⊕⊕⊝⊝ 1,2,3 Low | Primary outcome, difference was not statistically significant |
| PSG - SOL Follow-up: 4 months | Mean SOL in Control Groups was 21.06 minutes | MD 0.8 higher (6.13 lower to 7.73 higher) | 145 participants (4 studies) | ⊕⊝⊝⊝ 2,3,4 Very low | Primary outcome, difference was not statistically significant |
| PSG - SE Follow-up: 4 months | Mean SE in Control Groups was 79.02% | MD 0.9 lower (4.52 lower to 2.73 higher) | 145 participants (4 studies) | ⊕⊕⊝⊝ 2,4 Low | Primary outcome, difference was not statistically significant |
| PSG - WASO Follow-up: 4 months | Mean WASO in Control Groups was 66.03 minutes | MD 0.79 higher (13.95 lower to 15.52 higher) | 145 participants (4 studies) | ⊕⊝⊝⊝ 2,3,4 Very low | Primary outcome, difference was not statistically significant |
| Sleep questionnaire – Insomnia Insomnia Severity Index (0 to 28 points, 0 is best). Follow-up: 4 months | Mean score in sleep questionnaire - insomnia in Control Groups was 9.36 | SMD 0.72 lower (1.1 lower to 0.34 lower) | 121 participants (3 studies) | ⊕⊕⊕⊕ 1,2 High | Primary outcome, difference was statistically significant |
| Sleep questionnaire - Pittsburgh Sleep Questionnaire Index (0 to 21 points, >5 indicates good sleep quality). Follow-up: 4 months | Mean score in sleep questionnaire - PSQI in Control Groups was 6.83 | MD 3.17 lower (4.23 lower to 2.12 lower) | 108 participants (3 studies) | ⊕⊝⊝⊝ 1,2,3,5 Very low | Primary outcome, difference was statistically significant |
| Sleep diary - TST Follow-up: 4 months | Mean TST according to sleep diary in Control Groups was 334.25 minutes | MD 47.72 higher (46.92 higher to 48.52 higher) | 97 participants (2 studies) | ⊕⊕⊕⊝ 1,2,5 Moderate | Secondary outcome, difference was statistically significant |
* The basis for the assumed risk ( e.g . the median Control Group risk across studies) is provided in footnotes. The corresponding risk (and its 95%CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95%CI).
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1. Risk of bias: all studies had some methodological flaws and results involved a risk of bias.
2. Indirectness: the total number of events and/or number of participants was small; although outcomes are similar, interventions differ among studies.
3. Imprecision: very large confidence interval, with high level of imprecision.
4. Risk of bias: all studies had serious methodological flaws and results involved a high risk of bias.
5. Inconsistency: there was considerable heterogeneity.
95%CI: confidence interval 95%; RR: risk ratio; TST: total sleep time; SE: sleep efficiency; SOL: sleep onset latency; PSG: polysomnography; WASO: wake after sleep onset; SMD: standardized mean difference; MD: mean difference; PSQI: Pittsburgh Sleep Quality Index.
Figure 3Forest plot illustrating 95% confidence intervals derived from studies examining the effect of exercise on total sleep time measured using polysomnography (n=145)
Figure 4Forest plot illustrating 95% confidence intervals derived from three studies examining the effects of exercise on subjective perception of insomnia as per the Insomnia Severity Index and the Athens Insomnia Scale (n=121)
Grading of Recommendations Assessment, Development and Evaluations (GRADE) summary of outcomes of selected randomized controlled trials
| Outcomes | Number of studies | Risk of bias | Indirect evidence | Inaccuracy | Inconsistency | Number of participants | Relative effect (95%CI) | Quality of evidence (GRADE) | Clinical outcome, significance |
|---|---|---|---|---|---|---|---|---|---|
| TST minutes (PSG) | 3 | Severe 1 | Severe 2 | Severe 3 | Not severe | 121 | SMD: 0.95 (-0.46-2.36) | ⨁◯◯◯ Very low | Primary outcome, difference was not statistically significant |
| SOL minutes (PSG) | 4 | Very severe 4 | Severe 2 | Severe 3 | Not severe | 145 | MD: 0.8 (-6.13-7.73) | ⨁⨁◯◯ Low | Primary outcome, difference was not statistically significant |
| SE % (PSG) | 4 | Very severe 4 | Severe 2 | Not severe | Not severe | 145 | MD: -0.9 (-4.52-2.73) | ⨁◯◯◯ Very low | Primary outcome, difference was not statistically significant |
| WASO minutes (PSG) | 4 | Very severe 4 | Severe 2 | severe 3 | Not severe | 145 | MD: - 0.79 (-13.95-15.52) | ⨁⨁◯◯ Low | Primary outcome, difference was not statistically significant |
| Severity of insomnia | 3 | Severe 1 | Severe 2 | Not severe | Not severe | 121 | SMD: -0.72 (-1.1, -0.34) | ⨁⨁⨁⨁ High | Primary outcome, difference was statistically significant |
| Sleep quality (PSQI) | 3 | Severe 1 | Severe 2 | Severe 3 | Very severe 5 | 108 | MD: -3.17 (-4.23, -2.12) | ⨁◯◯◯ Very low | Primary outcome, difference was statistically significant |
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1. Risk of bias: all studies had some methodological flaws and results involved a risk of bias.
2. Indirectness: the total number of events and/or number of participants was small; although outcomes are similar, interventions differ among studies.
3. Imprecision: very large confidence interval, with high level of imprecision.
4. Risk of bias: all studies had serious methodological flaws and results involved a high risk of bias.
5. Inconsistency: there was considerable heterogeneity.
PSG: polysomnography; PSQI: Pittsburgh Sleep Quality Index; MD: mean difference; SMD: standardized mean difference; TST: total sleep time; SE: sleep efficiency; SOL: sleep onset latency; WASO: wake after sleep onset.